Breaking News Instant updates and real-time market news.

ATRS

Antares Pharma

$2.63

-0.05 (-1.87%)

04:55
07/11/18
07/11
04:55
07/11/18
04:55

Antares Pharma management to meet with Jefferies

Meeting to be held in Boston on July 11 hosted by Jefferies.

  • 11

    Jul

ATRS Antares Pharma
$2.63

-0.05 (-1.87%)

10/23/17
MSCO
10/23/17
NO CHANGE
Target $26
MSCO
Overweight
Antares CRL should have limited read through to Amag, says Morgan Stanley
After Antares Pharma (ATRS) announced that it has received a FDA complete response letter about the new drug application for Xyosted due to two deficiencies related to clinical data, Morgan Stanley analyst Thomas Smith said the CRL should have limited read through to Amag Pharmaceuticals (AMAG), which has partnered with Antares for technology being used in subcutaneous Makena. The CRL is not related to the device or manufacturing, noted Smith, who adds that investor relief over the minimal Makena read through could lead to a rally in Amag shares following the recent weakness. He keeps 60% probability of success for Makena SC and maintains an Overweight rating on Amag shares.
10/23/17
RAJA
10/23/17
NO CHANGE
Target $3.4
RAJA
Strong Buy
Antares Pharma maintained as a Strong Buy at Raymond James
Raymond James analyst Elliot Wilbur said the FDA's CRL on Antares Pharma (ATRS) XYOSTED was an unexpected and significant setback, but weakness in shares since the October disclosure effectively prices XYOSTED at zero, and substantially undervalues other development programs, especially ANDA products with Teva (TEVA). Wilbur is not writing-off XYSTED yet and is pushing out an expected launch to 2H19 from early 2018 previously, and is now discounting the probability of success at 50% versus 100% prior to the CRL. The analyst maintains asset values for Antares' non-XYOSTED assets are worth $2.50 per share using a sum-of-the-parts valuation and adjusted his price target to $3.40 from $4.20 on shares. Wilbur maintains a Strong Buy rating on Antares
10/23/17
JANY
10/23/17
NO CHANGE
JANY
Neutral
Antares CRL doesn't raise issues for Amag Pharmaceuticals, says Janney Capital
Janney Capital analyst Ken Trbovich noted that the FDA complete response letter issued to Antares (ATRS) for Xyosted did not pertain to the Quickshot subcutaneous autoinjector, which raises his confidence the FDA will not identify such issues as a short coming of the sNDA for Amag Pharmaceuticals' (AMAG) Makena SQ. However, he keeps a Neutral rating on Amag shares, noting that the primary uncertainty for the sNDA for Makena SQ is the fact that its peak plasma levels is higher than the upper bound the FDA uses to define bioequivalence.
05/08/18
HCWC
05/08/18
NO CHANGE
Target $4
HCWC
Buy
Antares target raised to $4 on higher Xyosted confidence at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat said that Antares Pharma reported "solid" Q1 results but "most importantly...finally explicitly confirmed a key aspect of the Xyosted filing," specifically that the company already conducted an ambulatory blood pressure monitoring study as part of the supplemental safety study ahead of the NDA submission. That fact, along with Antares' ability to re-submit the NDA just a week after receiving the minutes from the FDA Type-A meeting, increases his confidence in Xyosted approval coming in 2018, Livnat said. He raised his view of Xyosted's probability of success to 70% from 40% and increased his price target to $4 from $3.50 on Antares shares. Livnat keeps a Buy rating on the stock.

TODAY'S FREE FLY STORIES

BKD

Brookdale Senior Living

$8.93

0.175 (2.00%)

15:58
10/18/18
10/18
15:58
10/18/18
15:58
Hot Stocks
Brookdale Senior Living cancels from Credit Suisse conference, Bloomberg says »

Brookdale Senior Living…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 11

    Dec

CORT

Corcept Therapeutics

$12.46

-0.41 (-3.19%)

, TEVA

Teva

$21.25

0.06 (0.28%)

15:51
10/18/18
10/18
15:51
10/18/18
15:51
Hot Stocks
Corcept slides after Teva gets tentative approval for generic version of Korlym »

An ANDA submitted by Teva…

CORT

Corcept Therapeutics

$12.46

-0.41 (-3.19%)

TEVA

Teva

$21.25

0.06 (0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

GBT

Global Blood Therapeutics

$38.20

2.42 (6.76%)

15:48
10/18/18
10/18
15:48
10/18/18
15:48
Recommendations
Global Blood Therapeutics analyst commentary  »

Piper Jaffray says FDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Dec

ADP

ADP

$142.68

-1.02 (-0.71%)

15:45
10/18/18
10/18
15:45
10/18/18
15:45
Options
ADP call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 31

    Oct

XOMA

Xoma

$14.38

-1.65 (-10.29%)

, NVS

Novartis

$86.17

0.83 (0.97%)

15:40
10/18/18
10/18
15:40
10/18/18
15:40
Hot Stocks
Breaking Hot Stocks news story on Xoma, Novartis »

Xoma drops 15% after…

XOMA

Xoma

$14.38

-1.65 (-10.29%)

NVS

Novartis

$86.17

0.83 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 07

    Nov

XOMA

Xoma

$14.38

-1.65 (-10.29%)

15:39
10/18/18
10/18
15:39
10/18/18
15:39
Hot Stocks
Xoma says Novartis disclosed CRL received from FDA for canakinumab »

As previously announced,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HWBK

Hawthorn Bancshares

$23.65

(0.00%)

15:36
10/18/18
10/18
15:36
10/18/18
15:36
Hot Stocks
Hawthorn Bancshares to sell Branson, MO branch »

Hawthorn Bank, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDSO

Medidata

$70.82

1.45 (2.09%)

15:36
10/18/18
10/18
15:36
10/18/18
15:36
Recommendations
Medidata analyst commentary  »

Medidata price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

ISRG

Intuitive Surgical

$523.21

-19.64 (-3.62%)

15:34
10/18/18
10/18
15:34
10/18/18
15:34
Options
Intuitive Surgical options imply 7.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

CMCSA

Comcast

$36.11

-0.28 (-0.77%)

15:32
10/18/18
10/18
15:32
10/18/18
15:32
Hot Stocks
Comcast says it is now the largest provider of Gigabit Internet »

Comcast announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PTLA

Portola Pharmaceuticals

$22.02

-1.65 (-6.97%)

15:21
10/18/18
10/18
15:21
10/18/18
15:21
Hot Stocks
Breaking Hot Stocks news story on Portola Pharmaceuticals »

James E. Flynn reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Dec

ETFC

E-Trade

$48.86

-1.71 (-3.38%)

15:19
10/18/18
10/18
15:19
10/18/18
15:19
Options
E Trade options imply 7.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
10/18/18
10/18
15:17
10/18/18
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
10/18/18
10/18
15:16
10/18/18
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTZ

Hertz

$15.11

-1.35 (-8.20%)

15:15
10/18/18
10/18
15:15
10/18/18
15:15
Options
Hertz put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Nov

15:10
10/18/18
10/18
15:10
10/18/18
15:10
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

AXP

American Express

$102.92

-1.47 (-1.41%)

15:04
10/18/18
10/18
15:04
10/18/18
15:04
Options
American Express options imply 4.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 05

    Nov

TEVA

Teva

$21.27

0.08 (0.38%)

15:03
10/18/18
10/18
15:03
10/18/18
15:03
Hot Stocks
FDA reports tentative approval for Actavis' ANDA for Pimecrolimus »

Actavis is a unit of Teva…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

ACHC

Acadia

$38.63

2.86 (8.00%)

15:03
10/18/18
10/18
15:03
10/18/18
15:03
Recommendations
Acadia analyst commentary  »

Acadia could be worth $43…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISRG

Intuitive Surgical

$525.36

-17.49 (-3.22%)

14:59
10/18/18
10/18
14:59
10/18/18
14:59
Earnings
Fly Intel: What to watch in Intuitive Surgical earnings report »

Intuitive Surgical (ISRG)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

NTAP

NetApp

$78.07

-0.99 (-1.25%)

14:55
10/18/18
10/18
14:55
10/18/18
14:55
Options
NetApp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

14:50
10/18/18
10/18
14:50
10/18/18
14:50
General news
Canada retail sales preview »

Canada retail sales…

14:50
10/18/18
10/18
14:50
10/18/18
14:50
General news
Canada CPI preview »

Canada CPI preview:…

BKD

Brookdale Senior Living

$8.68

-0.07 (-0.80%)

14:49
10/18/18
10/18
14:49
10/18/18
14:49
Hot Stocks
Brookdale Senior Living moves off lows, said to cancel out of conference »

An afternoon move off the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 11

    Dec

PYPL

PayPal

$77.79

-2.32 (-2.90%)

14:49
10/18/18
10/18
14:49
10/18/18
14:49
Options
PayPal options imply 9.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.